Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease

Autor: Emi Yokoyama, Hiroyuki Ohigashi, Yuta Hasegawa, Xuanzhong Chen, Kazutoshi Aoyama, Satomi Matsuoka, Hideyo Oka, Eiko Hayase, Masanori Kadowaki, Masahiro Onozawa, Daigo Hashimoto, Koichi Akashi, Takahiro Tateno, Takanori Teshima, Kiyoshi Takeda
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Haematologica. 105(1):226-234
ISSN: 0390-6078
Popis: Myeloid differentiation factor 88 (MyD88) signaling has a crucial role in activation of both innate and adoptive immunity. MyD88 transduces signals via Toll-like receptor and interleukin-1 receptor superfamily to the NFκB pathway and inflammasome by forming a molecular complex with interleukin-1 receptor-associated kinase 4. The MyD88/interleukin-1 receptor-associated kinase 4 pathway plays an important role, not only in innate immunity, but also T-cell immunity; however, its role in donor T cells on the pathophysiology of graft-versus-host disease (GvHD) remains to be elucidated. We addressed this issue by using MyD88-deficient T cells in a mouse model of allogeneic hematopoietic stem cell transplantation (allo-SCT). While MyD88-deficient and wild-type T cells proliferated equivalently after transplantation, MyD88-deficient T cells demonstrated impaired survival and differentiation toward Th1, Tc1, and Th17, and induced less severe GvHD compared to wild-type T cells. Administration of interleukin-1 receptor-associated kinase 4 inhibitor PF-06650833 significantly ameliorated GvHD after allo-SCT. These results thus demonstrate that donor T-cell MyD88/interleukin-1 receptor-associated kinase 4 pathway is a novel therapeutic target against GvHD after allo-SCT.
Databáze: OpenAIRE